Immunome Inc. SEC filings IMNM
Immunome Inc. has 460 filings in SEC EDGAR's recent list, going back to Sep 14, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 11, 2026 | — |
| S-8 | Employee stock plan registration | Mar 3, 2026 | — |
| 424B5 | Prospectus supplement | Dec 17, 2025 | — |
| 424B5 | Prospectus supplement | Dec 15, 2025 | — |
| S-8 | Employee stock plan registration | Mar 19, 2025 | — |
| 424B5 | Prospectus supplement | Jan 30, 2025 | — |
| 424B5 | Prospectus supplement | Jan 29, 2025 | — |
| S-3ASR | Automatic shelf registration | Nov 22, 2024 | — |
| S-3ASR | Automatic shelf registration | Oct 8, 2024 | — |
| 424B5 | Prospectus supplement | May 14, 2024 | — |
| S-3ASR | Automatic shelf registration | Apr 3, 2024 | — |
| S-3ASR | Automatic shelf registration | Apr 3, 2024 | — |
| 424B5 | Prospectus supplement | Feb 14, 2024 | — |
| 424B5 | Prospectus supplement | Feb 13, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 13, 2024 | — |
| S-8 | Employee stock plan registration | Feb 2, 2024 | — |
| S-3 | Shelf registration | Nov 16, 2023 | — |
| S-8 POS | Filing | Nov 2, 2023 | — |
| 424B3 | Prospectus | Aug 28, 2023 | — |
| S-4/A | Filing | Aug 25, 2023 | — |
| S-4 | Registration for a merger or exchange | Aug 8, 2023 | — |
| 424B5 | Prospectus supplement | Mar 16, 2023 | — |
| S-8 | Employee stock plan registration | Mar 16, 2023 | — |
| S-3 | Shelf registration | Oct 1, 2021 | — |
| S-1/A | Amended registration statement | May 26, 2021 | — |
| S-1/A | Amended registration statement | May 21, 2021 | — |
| S-1 | Registration statement | May 11, 2021 | — |
| S-8 | Employee stock plan registration | Mar 25, 2021 | — |
| 424B4 | Prospectus | Oct 5, 2020 | — |
| S-1MEF | Filing | Oct 1, 2020 | — |
| S-1/A | Amended registration statement | Sep 24, 2020 | — |
| S-1 | Registration statement | Sep 9, 2020 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMNM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bothell, WA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1472012
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.